294 related articles for article (PubMed ID: 33539852)
41. Nanocarriers Based Ocular Therapeutics: Updates, Challenges and Future Prospectives.
Kaushal U; Kaur M; Nagpal M; Bhuyan M; Gounder KP
Curr Drug Res Rev; 2023; 15(1):15-28. PubMed ID: 36100986
[TBL] [Abstract][Full Text] [Related]
42. Disposition of nanoparticle-based delivery system via inner ear administration.
Chen G; Zhang X; Yang F; Mu L
Curr Drug Metab; 2010 Dec; 11(10):886-97. PubMed ID: 21208174
[TBL] [Abstract][Full Text] [Related]
43. Molecular targeting of liposomal nanoparticles to tumor microenvironment.
Zhao G; Rodriguez BL
Int J Nanomedicine; 2013; 8():61-71. PubMed ID: 23293520
[TBL] [Abstract][Full Text] [Related]
44. Nanoparticle approaches to combating drug resistance.
Moon JH; Moxley JW; Zhang P; Cui H
Future Med Chem; 2015 Aug; 7(12):1503-10. PubMed ID: 26334205
[TBL] [Abstract][Full Text] [Related]
45. Nanocarriers for oral drug delivery.
Zhang L; Wang S; Zhang M; Sun J
J Drug Target; 2013 Jul; 21(6):515-27. PubMed ID: 23621127
[TBL] [Abstract][Full Text] [Related]
46. Chitosan in mucoadhesive drug delivery: focus on local vaginal therapy.
Andersen T; Bleher S; Eide Flaten G; Tho I; Mattsson S; Škalko-Basnet N
Mar Drugs; 2015 Jan; 13(1):222-36. PubMed ID: 25574737
[TBL] [Abstract][Full Text] [Related]
47. Topical delivery of ocular therapeutics: carrier systems and physical methods.
Souza JG; Dias K; Pereira TA; Bernardi DS; Lopez RF
J Pharm Pharmacol; 2014 Apr; 66(4):507-30. PubMed ID: 24635555
[TBL] [Abstract][Full Text] [Related]
48. Innovations in Liposomal DDS Technology and Its Application for the Treatment of Various Diseases.
Oku N
Biol Pharm Bull; 2017; 40(2):119-127. PubMed ID: 28154249
[TBL] [Abstract][Full Text] [Related]
49. Hydrogel nanoparticles and nanocomposites for nasal drug/vaccine delivery.
Salatin S; Barar J; Barzegar-Jalali M; Adibkia K; Milani MA; Jelvehgari M
Arch Pharm Res; 2016 Sep; 39(9):1181-92. PubMed ID: 27352214
[TBL] [Abstract][Full Text] [Related]
50. Agranulocytosis-Protective Olanzapine-Loaded Nanostructured Lipid Carriers Engineered for CNS Delivery: Optimization and Hematological Toxicity Studies.
Gadhave DG; Tagalpallewar AA; Kokare CR
AAPS PharmSciTech; 2019 Jan; 20(1):22. PubMed ID: 30604305
[TBL] [Abstract][Full Text] [Related]
51. Thermolabile liposomes: a controlled release delivery tool in diagnosis/therapy in experimental pulmonary ɶdema.
Santos AC; Matos CM; Oliveiros B; Almeida T; Gano L; Neves M; Ferreira N
Curr Radiopharm; 2012 Apr; 5(2):166-74. PubMed ID: 22280109
[TBL] [Abstract][Full Text] [Related]
52. Cyclosporine A delivery to the eye: a pharmaceutical challenge.
Lallemand F; Felt-Baeyens O; Besseghir K; Behar-Cohen F; Gurny R
Eur J Pharm Biopharm; 2003 Nov; 56(3):307-18. PubMed ID: 14602172
[TBL] [Abstract][Full Text] [Related]
53. Avoiding a Sticky Situation: Bypassing the Mucus Barrier for Improved Local Drug Delivery.
Zierden HC; Josyula A; Shapiro RL; Hsueh HT; Hanes J; Ensign LM
Trends Mol Med; 2021 May; 27(5):436-450. PubMed ID: 33414070
[TBL] [Abstract][Full Text] [Related]
54. Nanoparticle-based drug delivery to the vagina: a review.
Ensign LM; Cone R; Hanes J
J Control Release; 2014 Sep; 190():500-14. PubMed ID: 24830303
[TBL] [Abstract][Full Text] [Related]
55. Development of risperidone liposomes for brain targeting through intranasal route.
Narayan R; Singh M; Ranjan O; Nayak Y; Garg S; Shavi GV; Nayak UY
Life Sci; 2016 Oct; 163():38-45. PubMed ID: 27593571
[TBL] [Abstract][Full Text] [Related]
56. Nanoparticles for nasal vaccination.
Csaba N; Garcia-Fuentes M; Alonso MJ
Adv Drug Deliv Rev; 2009 Feb; 61(2):140-57. PubMed ID: 19121350
[TBL] [Abstract][Full Text] [Related]
57. Drug Delivery Approaches in Addressing Clinical Pharmacology-Related Issues: Opportunities and Challenges.
Wen H; Jung H; Li X
AAPS J; 2015 Nov; 17(6):1327-40. PubMed ID: 26276218
[TBL] [Abstract][Full Text] [Related]
58. Effect of poly(ethylene glycol) on insulin stability and cutaneous cell proliferation in vitro following cytoplasmic delivery of insulin-loaded nanoparticulate carriers - A potential topical wound management approach.
Abdelkader DH; Osman MA; El-Gizawy SA; Hawthorne SJ; Faheem AM; McCarron PA
Eur J Pharm Sci; 2018 Mar; 114():372-384. PubMed ID: 29288081
[TBL] [Abstract][Full Text] [Related]
59. Nanocrystal for ocular drug delivery: hope or hype.
Sharma OP; Patel V; Mehta T
Drug Deliv Transl Res; 2016 Aug; 6(4):399-413. PubMed ID: 27165145
[TBL] [Abstract][Full Text] [Related]
60. Recent Advances and Perspectives in Liposomes for Cutaneous Drug Delivery.
Carita AC; Eloy JO; Chorilli M; Lee RJ; Leonardi GR
Curr Med Chem; 2018 Feb; 25(5):606-635. PubMed ID: 28990515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
